Abstract
Changing at-risk populations and treatments are reshaping screening and management. Which regimens are best and what factors influence treatment choices?
MeSH terms
-
Family Practice / methods*
-
Hepatitis C* / diagnosis
-
Hepatitis C* / epidemiology
-
Hepatitis C* / therapy
-
Hepatitis C* / virology
-
Humans
-
Mass Screening* / methods
-
Mass Screening* / organization & administration
-
Mass Screening* / trends
-
Patient Care Management / trends*
-
Population Growth*
-
Risk Factors
-
United States / epidemiology